Genetics of Neurodegenerative Diseases

The genetics of neurodegenerative diseases involves studying how genetic variations contribute to the development and progression of disorders such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis . Researchers have identified specific genes associated with these diseases, including APP, PSEN1, and PSEN2 for Alzheimer's, and SNCA, LRRK2, and PARK2 for Parkinson's. Mutations in the HTT gene cause Huntington's disease, while SOD1, TDP-43, and FUS are linked to ALS. Understanding these genetic factors helps elucidate the molecular mechanisms underlying neurodegeneration. Advanced techniques such as genome-wide association studies  and next-generation sequencing  are used to identify new genetic variants and pathways involved in these diseases. Epigenetic factors, including DNA methylation and histone modification, are also being studied for their role in gene expression regulation in neurodegeneration. Familial forms of neurodegenerative diseases, which are inherited, provide critical insights into the genetic basis of these conditions. Research is also focused on identifying genetic risk factors in sporadic cases, which occur without a clear family history. The identification of genetic biomarkers aids in early diagnosis and the development of targeted therapies. Gene therapy is emerging as a potential treatment strategy, aiming to correct or mitigate the effects of harmful genetic mutations. Personalized medicine approaches are being developed to tailor treatments based on an individual's genetic profile. Collaborative efforts in biobanking and data sharing are accelerating discoveries in the field. The integration of genetics with other biological data, such as proteomics and metabolomics, provides a more comprehensive understanding of neurodegenerative diseases. Ultimately, genetic research is paving the way for more effective interventions and preventative strategies for these debilitating conditions.

    Related Conference of Genetics of Neurodegenerative Diseases

    February 03-04, 2025

    37th World Conference on Neurology

    London, UK
    February 17-18, 2025

    5th International Conference on Child Neurology

    Aix-en-Provence, France
    February 20-21, 2025

    6th International Conference on Neurologists

    Amsterdam, Netherlands
    February 24-25, 2025

    4th International Conference onAlzheimer and Dementia

    Madrid, Spain
    February 27-28, 2025

    7th World Depression Congress

    Paris, France
    March 10-11, 2025

    8th World Conference on Neuroscience

    Paris, France
    March 13-14, 2025

    7th World Conference on Neuroscience

    Prague, Czech Republic
    March 24-25, 2025

    38th European Neurology Congress 2025

    London, UK
    April 24-25, 2025

    6th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    April 29-30, 2025

    11th International Conference on Epilepsy & Treatment

    Barcelona, Spain
    May 12-13, 2025

    39th European Neurology Congress

    London, UK
    July 17-18, 2025

    31st Annual Summit on Neuroscience & Neurological Disorders

    Amsterdam, Netherlands
    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France
    July 28-29, 2025

    35th World Congress on Neurology and Neuroscience

    Paris, France
    August 25-26, 2025

    20th Annual Congress on Neuroscience

    Aix-en-Provence, France
    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    November 13-14, 2025

    38th International Conference on Neuroscience and Neurochemistry

    Aix-en-Provence, France

    Genetics of Neurodegenerative Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in